Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Immune responses after COVID-19 vaccination should be evaluated in different populations around the world. This study compared antibody responses induced by ChAdOx1 nCoV-19, CoronaVac, and BNT162b2 vaccines. Blood samples from vaccinees were collected pre- and post-vaccinations with the second and t...
Main Authors: | Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, Déborah dos Anjos, Miriam Leandro Dorta, João Victor Batalha-Carvalho, Ana Maria Moro, Pedro Roosevelt Torres Romão, Menira Souza, Fabiola Souza Fiaccadori, Simone Gonçalves Fonseca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/7/1183 |
Similar Items
-
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
by: Thiago Cerqueira-Silva, et al.
Published: (2022-07-01) -
Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
by: Hazal Cansu Çulpan, et al.
Published: (2023-12-01) -
Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine
by: Marcela Helena Gambim Fonseca, et al.
Published: (2022-06-01) -
Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines
by: Serkan Atıcı, et al.
Published: (2023-07-01) -
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01)